Cover Image
市場調查報告書

生物晶片的全球市場

Biochips

出版商 Global Industry Analysts, Inc. 商品編碼 236719
出版日期 內容資訊 英文 292 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生物晶片的全球市場 Biochips
出版日期: 2016年02月01日 內容資訊: 英文 292 Pages
簡介

本報告提供全球生物晶片市場相關調查,為您彙整該市場的總括性趨勢與DNA生物晶片,蛋白質生物晶片,實驗室晶片等各市場區隔趨勢,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 生物晶片:序論
    • 擴大的應用領域
    • 現在及未來分析
    • DNA生物晶片領導應用
    • 蛋白質生物晶片:穩定擴大
    • 實驗室晶片:奈米技術和遺傳因子工程學的融合
    • 實驗室晶片技術的主要應用
    • 推動成長要素/市場趨勢
    • 開發藥劑中生物晶片的應用
    • 癌症:重要的推動因素
    • 文明病的罹患率上升促進診斷微陣列市場
    • 政府致力於生物晶片技術的推廣 其他
  • 生物晶片產業的技術創新
  • 競爭
    • 產業結構
    • 主要參與企業
    • 醫藥品及生物科技企業的合作擴大
    • 外包:順利
  • 產品概要
  • 生物晶片和微陣列結構
  • 生物晶片的應用
    • 生物晶片的使用
    • 醫藥品研究
    • 醫療診斷
    • 生物感應器晶片技術的進步
    • 司法鑑定
    • 移植篩檢
    • 鑑定檢驗
    • 水·環境檢驗
    • 食品產業
  • 產品引進
  • 近幾年的產業活動
  • 主要企業
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cepheid Inc.
    • Fluidigm Corporation
    • GE Healthcare Ltd.
    • Hoffman-La-Roche Ltd.
    • Illumina, Inc.
    • Ocimum Biosolutions Ltd.
    • PerkinElmer, Inc.
    • TaKaRa BIO株式會社
    • Clontech Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他各國

競爭環境

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1026

This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others. The report further analyzes the market by the following Applications: Research, Diagnostics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -

Affymetrix, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Cepheid Inc.
Fluidigm Corporation

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • A. DNA Biochips
    • B. Protein Biochips
    • C. Lab-on-a-Chip
    • D. Others

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Biochips - A Primer
  • Expanding Application Areas
  • Current & Future Analysis
  • DNA Biochips Lead the Application Front
  • Protein Biochips - Set for Robust Expansion
  • Lab-on-a-Chip: Fusion of Nanotechnology & Genetic Engineering
  • Key Applications of Lab-on-a-Chip Technology
  • Molecular Biology and Lab-On-A-Chip
  • Proteomics and Lab-On-A-Chip
  • Cell Biology and Lab-On-A-Chip
  • Chemistry and Lab-On-A-Chip
  • Growth Drivers/Market Trends
  • Proteomics and Genomics Drive Demand for Biochips
  • Growing Preference for DNA/Protein Biochips in Personalized Medicine
  • Application of Biochips in Drug Discovery - A Strong Growth Driver
  • Cancer: An Important Driver for the Biochips Market
    • Table 1: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 2: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal, and Liver Cancers (includes corresponding Graph/Chart)
    • Table 3: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus, and Liver Cancers (includes corresponding Graph/Chart)
  • Increasing Prevalence of Lifestyle Diseases Boost Diagnostic Microarray Market
    • Table 4: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart)
    • Table 5: Percentage Increase in DM Incidence among Ages 20-79 Worldwide by Geographic Region: 2013-2035 (includes corresponding Graph/Chart)
  • Government Efforts to Promote Biochip Technology
  • Integrating Tools with Diagnostic Capabilities with Smartphones - A Futuristic Trend
  • Microfluidic and Lab-on-a-chip Devices for Pharmacogenomics
  • Lab-on-a-Chip System for Better Pulmonary Disease Outcome
  • Industry Challenges
  • Standardization: A Key Challenge
  • High Costs Restrain Growth
  • Precise Protein Detection: A Challenge

2. INNOVATIONS IN THE BIOCHIPS INDUSTRY

  • Biochip Innovations in Drug Discovery Applications
  • HuRELflow
  • MetaChip and Subsequent Versions
  • Lab-on-a-Chip Devices in Smart Delivery of Drugs
  • Biochips from AYOXXA: A Giant Leap in Protein Multiplexing
  • Key Developments in the Past

3. COMPETITION

  • Industry Structure
  • Major Participants
  • Affymetrix: A Pioneer Player
  • Growing Partnerships between Pharma and Biotech Companies
  • Outsourcing: A Positive Trend

4. PRODUCT OVERVIEW

  • Biochips - Complex Blend of Biochemistry and Electronics
  • Historical Perspective
  • Promising Biochips Promote Biological Research
  • Lab-on-a-chip: An Enabled Technology
  • Utility
  • Evolution and Segmentation
  • Differing Perspectives
  • Classification of Biochips
  • Need for Biochips
  • Manufacturing Systems Used in Biochip Manufacture
  • Working of a Biochip
  • DNA Transcription & Translation through A Biochip
  • A Functional Model
  • Cocktail of Disparate Technically Specialized Applications
  • Biochips: By-product of Multi-disciplinary Sciences
  • Nanotechnology
  • BioMEMS
  • Microfluidics
  • Micro Total Analysis System

5. BIOCHIP AND MICROARRAY CONSTRUCTION

  • Chip Architecture
  • Essence of a Biochip
  • Concept of a Microarray
  • Microarray Modules
  • High Degree of Automation Spurs Biochips Use
  • Microfabrication Technology in Biochips made from Polymer and Plastics
  • Micro-optics in Biochips
  • Liquid Handling Through Micro-Dispensers
  • Capillary Electrophoresis and Electrochemical Detectors
  • Other Technologies
  • Management of Bio-information
  • Scanning
  • Microarray Database Management
  • Classification of DNA Chips
  • General Description of Spotted cDNA Microarrays
  • Spotted DNA Arrays
  • Spotted cDNA Versus Spotted Oligonucleotide Arrays
  • Limitations of Conventional cDNA Microarrays
  • Protein Biochips
  • General Applications of Protein Biochips:
  • Challenges in the Design of a Protein Biochip
  • Limitations of Protein Chip Technology
  • Concluding Remarks for Protein Biochips

6. APPLICATIONS OF BIOCHIPS

  • Biochip Uses
  • Pharmaceutical Investigation
  • Medical Diagnostics
  • Advantages of Biosensor Chip Technology
  • Forensics
  • Transplantation Screening
  • Identity Testing
  • Water and Environmental Testing
  • Food Industry

7. PRODUCT INTRODUCTIONS

  • Veredus Laboratories and AVA Launch VereVet(tm) Lab-on-Chip Application
  • Eurofins Scientific Launches Analytical DNA Chip Technology
  • Agilent Technologies Introduces Updated SurePrint Microarrays
  • Agilent Technologies Launches GenetiSure Pre-Screen Microarray
  • Agilent Technologies Launches Updates to SurePrint miRNA Microarrays
  • Clontech Laboratories Launches DNA SMART ChIP-Seq Kit
  • PerkinElmer Launches LabChip(r) GX Touch Automated Electrophoresis Systems
  • Cancer Genetics Launches Urogenital Cancer Array UroGenRA
  • A STAR and Veredus Launch VereTrop(tm) Biochip

8. RECENT INDUSTRY ACTIVITY

  • Sengenics Acquires Oxford Gene Technology's Protein Array Technology
  • Immucor Acquires Sentilus
  • SQI Diagnostics Expands Collaboration with Global Pharmaceutical Company
  • Agenix Enters into Cross-Licensing Agreement with Arrayjet Limited
  • CombiMatrix and Manhattan Labs Enter into Distribution Partnership
  • Sequenom and CombiMatrix Enter Into Collaboration Agreement

9. FOCUS ON SELECT GLOBAL PLAYERS

  • Affymetrix, Inc. (US)
  • Agilent Technologies, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Cepheid Inc. (US)
  • Fluidigm Corporation (US)
  • GE Healthcare Ltd. (UK)
  • Hoffman-La-Roche Ltd. (Switzerland)
  • Illumina, Inc. (US)
  • Ocimum Biosolutions Ltd. (India)
  • PerkinElmer, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • Clontech Laboratories, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)

10. GLOBAL MARKET PERSPECTIVE

    • Table 6: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 7: World Historic Review for Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 8: World 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 9: World Recent Past, Current & Future Analysis for DNA Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 10: World Historic Review for DNA Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 11: World 14-Year Perspective for DNA Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 12: World Recent Past, Current & Future Analysis for Protein Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for Protein Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 14: World 14-Year Perspective for Protein Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 15: World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 16: World Historic Review for Lab-on-a-Chip by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 17: World 14-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 18: World Recent Past, Current & Future Analysis for Other Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for Other Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 20: World 14-Year Perspective for Other Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 21: World Recent Past, Current & Future Analysis for Biochips by Application - Research, Diagnostics, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for Biochips by Application - Research, Diagnostics, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 23: World 14-Year Perspective for Biochips by Application - Percentage Breakdown of Dollar Sales for Research, Diagnostics, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • United States: The Global Leader for Biochips
    • Rising Demand in Biotechnology and Life Science Research Applications
    • Lab-on-a-Chip: The Leading Segment
    • Rapid Growth for Protein Biochips
    • DNA Biochip Market
    • Growth Drivers
      • Demand for Personalized Medicine Drives Market for Biochips
      • Aging Population: A Strong Demographic Driver
    • Table 24: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
    • Table 25: The US Population Breakdown by Age Group (2014) (includes corresponding Graph/Chart)
      • Growing Incidence of Cancer & Lifestyle Disorders
      • Opportunity Indicators: Statistics Depicting Increasing Incidence of Cancer and Lifestyle Disorders
    • Table 26: The US Cancer Incidence by Gender (2014): No. of Reported New Cases for Men and Women (includes corresponding Graph/Chart)
    • Table 27: The US Cancer Incidence by Affected Site (2014): Number of New Cancer Cases (includes corresponding Graph/Chart)
    • Table 28: Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group for the US (includes corresponding Graph/Chart)
    • Competition
    • Product Introductions
    • Strategic Corporate developments
    • Select Key Players
  • B. Market Analytics
    • Table 29: The US Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 30: The US Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 31: The US 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Rising Incidence of Chronic Diseases Spurs Biochips Demand
      • Opportunity Indicators for Biochips Market:
    • Table 32: New Cancer Cases in Canada by Gender and Affected Site (2012) (includes corresponding Graph/Chart)
    • Table 33: New Cancer Cases in Canada by Province (2012) (includes corresponding Graph/Chart)
    • Table 34: Prevalence of Diabetes Mellitus in Canada (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group (includes corresponding Graph/Chart)
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 35: Canadian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 36: Canadian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 37: Canadian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Elderly Population Boosts the Biochip Market
    • Table 38: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 39: Japanese Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 40: Japanese Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 41: Japanese 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Leader in the DNA Biochip Segment
    • Lab-on-chip Market in Europe
    • European Advancements Shape Diagnostic Procedures
    • Ageing Population Boosts Demand
    • Table 42: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart)
    • Opportunity Indicator for the Biochips Market: European Personalized Medicine Market Exhibits Robust Growth
    • Increasing Incidence of Cancer Drives Biochips Demand
    • Table 43: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 44: European Recent Past, Current & Future Analysis for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 45: European Historic Review for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 46: European 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 47: European Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 48: European Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 49: European 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Product Introduction
  • B. Market Analytics
    • Table 50: French Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 51: French Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 52: French 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Berlin, Brandenburg and Biochips
  • B. Market Analytics
    • Table 53: German Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 54: German Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 55: German 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Current & Future Analysis
  • B. Market Analytics
    • Table 56: Italian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 57: Italian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 58: Italian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate development
    • GE Healthcare Ltd. - A Key Player
  • B. Market Analytics
    • Table 59: UK Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 60: UK Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 61: UK 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 62: Spanish Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 63: Spanish Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 64: Spanish 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 65: Russian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 66: Russian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 67: Russian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • Market Analysis
    • Table 68: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 69: Rest of Europe Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 70: Rest of Europe 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Increased Healthcare Spending Boosts the Biochips Market
    • India & China Offer Significant Growth Opportunities
    • Table 71: China and India Lead Global Population (July 2013): Table Depicting China and India's Huge Population Vis-a-vis Other Countries' Population (in Million) by Age Group (includes corresponding Graph/Chart)
    • Rising Diabetes Incidence in Asia-Pacific Offers Significant Growth Opportunities
    • Table 72: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka
    • Table 73: Prevalence of Diabetes Mellitus in Western Asia-Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
  • B. Market Analytics
    • Table 74: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 75: Asia-Pacific Historic Review for Biochips by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 76: Asia-Pacific 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for China, and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 77: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 78: Asia-Pacific Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 79: Asia-Pacific 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Basic Environment and Commercial Development
    • Biochip Research Institutes
    • Favorable Personalized Medicine Market Boosts Demand for Biochips
  • B. Market Analytics
    • Table 80: Chinese Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 81: Chinese Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 82: Chinese 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5b. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • India: Growing Investments in Pharmacogenomics Research Drives Biochips Market
    • Product Introductions
    • Strategic Corporate Development
    • Ocimum Biosolutions Ltd. - A Key India-based Player
  • B. Market Analytics
    • Table 83: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 84: Rest of Asia-Pacific Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 85: Rest of Asia-Pacific 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 86: Latin American Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 87: Latin American Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 88: Latin American 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • Market Analysis
    • Table 89: Rest of World Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 90: Rest of World Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 91: Rest of World 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top